Related Experiment Video

Updated: Jan 25, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

Bronchiolitis: an update on management and prophylaxis

Konstantinos Karampatsas1, Jonathan Kong2, Jonathan Cohen3

  • 1Specialist Registrar in Paediatrics, Paediatric and Adolescent Division, University College Hospitals NHS Foundation Trust, London NW1 2BU.

British Journal of Hospital Medicine (London, England : 2005)
|May 7, 2019
PubMed

Insights

Bronchiolitis, a common UK childhood illness, is often caused by Respiratory Syncytial Virus (RSV). Current management focuses on supportive care, with limited effective treatments and developing vaccines offering future hope.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Bronchiolitis is a leading cause of hospitalization for children under two in the UK.
  • Respiratory Syncytial Virus (RSV) is the primary pathogen, associated with severe outcomes and high costs.
  • While generally self-limiting, severe cases occur in vulnerable infants.

Purpose of the Study:

  • To review the current management of bronchiolitis in the UK.
  • To highlight the limitations of existing treatments.
  • To discuss the development of new preventative strategies, particularly vaccines.

Main Methods:

  • Review of National Institute for Health and Care Excellence (NICE) guidelines for bronchiolitis management.
  • Summary of current supportive care practices.
  • Overview of pharmacological interventions and their limited efficacy.
  • Discussion of ongoing vaccine development efforts.

Main Results:

  • Supportive care, including fluid and respiratory support, remains the mainstay of bronchiolitis management.
  • Pharmacological treatments like bronchodilators, steroids, and antibiotics lack proven efficacy and are not recommended by NICE.
  • An existing monoclonal antibody offers passive immunization but is restricted due to cost.
  • Active immunization vaccines targeting RSV are under development for pregnant women and infants.

Conclusions:

  • Effective treatments for bronchiolitis are limited, emphasizing the need for preventative measures.
  • Vaccine development, especially for RSV, represents a significant future strategy for reducing disease burden.
  • Further research into novel therapeutics and widespread vaccine implementation is crucial.

More Related Videos

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.0K
Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

862

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
416
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
207
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
564
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
168
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
270